Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.

@article{Krejc1976ChangesIT,
  title={Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.},
  author={Pavel Krejc{\'i} and O. Marhan and M. Au{\vs}kov{\'a} and Karel Ře{\vz}{\'a}bek and M. Semonsk{\'y}},
  journal={Experientia},
  year={1976},
  volume={32 10},
  pages={1308-9}
}
The four days administration of D-6-methyl-8-[beta-isopropylaminoethyl]ergoline-I (VUFB-10726) to nursing rats decreases adenohypophyseal prolactin as determined with disc electrophoresis, and produces changes in the histological appearance of adenohypophyses, which indicate the inhibition of prolaction production and secretion.